Table 1.
Patient Characteristics
| Losartan Group (n = 48) | Control Group (n = 49) | P Value | |
|---|---|---|---|
| Age | 58.8 ± 13.19 | 59.55 ± 11.0 | 0.765 |
| Gender (female/male) | 9/39 | 11/38 | 0.653 |
| Cardiac risk factors, | |||
| Smoking | 32 (67) | 33 (67) | 0.943 |
| Diabetes mellitus | 8 (17) | 11 (22) | 0.473 |
| Hypertension | 27 (56) | 19 (39) | 0.085 |
| Lipidemia | 22 (46) | 28 (57) | 0.265 |
| Medication during in‐hospital period | |||
| Aspirin | 48 (100) | 49 (100) | 1 |
| Beta‐blocker | 12 (25) | 8 (16) | 0.291 |
| Statin | 43 (90) | 43 (88) | 0.776 |
| Management | 0.552 | ||
| Primary angioplasty | 18 (38) | 24 (49) | |
| Thrombolysis | 12 (24) | 10 (20) | |
| Delayed angioplasty | 18 (38) | 15 (31) | |
| Infact‐related artery | 0.095 | ||
| LAD | 23 (48) | 18 (37) | |
| LCX | 6 (12) | 15 (30) | |
| RCA | 19 (40) | 16 (33) | |
| Patent infact‐related artery | 35 (73) | 42 (86) | 0.119 |
| Coronary artery disease | 0.950 | ||
| One vessel disease | 21 (44) | 23 (47) | |
| Two vessel disease | 23 (48) | 22 (45) | |
| Three vessel disease | 4 (8) | 4 (8) | |
| Ejection fraction (%) | 46,50 ± 7.04 | 49.06 ± 7.17 | 0.081 |
Values are presented as number of patients (%) or mean ± SD.
LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right coronary artery.